{"id":2185,"date":"2015-08-20T05:01:28","date_gmt":"2015-08-20T05:01:28","guid":{"rendered":"http:\/\/nsbri.org\/?page_id=2185"},"modified":"2016-02-08T14:18:31","modified_gmt":"2016-02-08T14:18:31","slug":"medical-advances","status":"publish","type":"page","link":"http:\/\/nsbri.org\/impact\/medical-advances\/","title":{"rendered":"Medical Advances"},"content":{"rendered":"
[vc_row row_fullwidth=”0″ header=”0″][vc_column width=”1\/4″][vc_column_text]<\/p>\n
[\/vc_column_text][\/vc_column][vc_column width=”3\/4″][vc_column_text]<\/p>\n
The Institute conducted the first independent clinical test of the Vittamed device for noninvasive assessment of intracranial pressure. The results in normal subjects and patients were significant, and NSBRI worked with the manufacturer to make improvements to address NASA\u2019s needs. The device is being considered for operational use by NASA, and it also has applications in neurology and neurosurgery, where invasive measurement of intracranial pressure is one of the most commonly performed procedures.<\/p>\n